Müskens, W. D., Rongen-van Dartel, S. A. A., Teerenstra, S., Adang, E. M. M., & van Riel, P. L. C. M. (2020). One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology. Rheumatol Adv Pract.
Chicago-стиль цитированияMüskens, Wieland D., Sanne A A. Rongen-van Dartel, Steven Teerenstra, Eddy M M. Adang, and Piet L C M. van Riel. "One-year Results After Transitioning From Etanercept Originator to Biosimilar in a Setting Promoting Shared Decision-making in Rheumatology." Rheumatol Adv Pract 2020.
MLA-цитированиеMüskens, Wieland D., et al. "One-year Results After Transitioning From Etanercept Originator to Biosimilar in a Setting Promoting Shared Decision-making in Rheumatology." Rheumatol Adv Pract 2020.